top of page

Medication Options for Treatment of Stimulant Use Disorders: Optimistic Update and New Research

  • Ann Tucker
  • Feb 19, 2021
  • 1 min read

TUESDAY, MARCH 2nd / 12:00-1:00pm CT

Overdose deaths associated with illicit stimulants have surged in the past eight years, according to a recent study by the National Institutes for Health (NIH). While there are currently no FDA-approved medications for the treatment of individuals who are dependent on stimulants, new treatments utilizing readily available medications are showing encouraging empirical support.


Join the National Council for Behavioral Health as we examine the latest groundbreaking research in the context of current increases in stimulant use. Register here

 
 
 

Recent Posts

See All

Comments


Subscribe to the CLASPP Newsletter

Our members and supporters stay informed. From state and federal policy news to training and webinar events, funding opportunities and more, CLASPP brings it to you first.

Thanks for submitting!

© 2022 by CLASPP

bottom of page